Unstable blood sugar: This can lead to cravings, mood shifts, and feeling less full after meals
Just like GLP-1, GLP-1 receptor agonists signal the pancreas to produce more insulin and inhibit the production of glucagon, helping to lower blood sugar
outlined several systemic advantages of GLP-1 RAs, including weight loss, glycemic control, cardiovascular protection (e.g., reduced incidence of myocardial infarction and stroke), and their role as a non-surgical alternative to bariatric procedures
Typically, people qualify for this treatment if they have a body mass index (BMI) of 27 or higher along with weight-related health issues, or a BMI of 30 or more
From steatosis to cirrhosis: the role of obesity in the progression of liver disease